Stock TOI THE ONCOLOGY INSTITUTE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings The Oncology Institute, Inc.

Equities

TOI

US68236X1000

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
0.4942 USD +4.99% Intraday chart for The Oncology Institute, Inc. -5.87% -75.77%
May. 14 Transcript : The Oncology Institute, Inc., Q1 2024 Earnings Call, May 14, 2024
May. 14 The Oncology Institute, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • Low profitability weakens the company.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
THE ONCOLOGY INSTITUTE, INC. Stock The Oncology Institute, Inc.
-75.77% 34.59M - -
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+22.65% 87.14B
C+
CVS HEALTH CORPORATION Stock CVS Health Corporation
-23.68% 75.59B
B-
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+1.76% 26.78B
C+
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+3.99% 17.89B
A-
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-13.47% 16.44B
B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+2.68% 15.68B
A-
NATERA, INC. Stock Natera, Inc.
+69.13% 13.3B
C-
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+74.99% 13.06B
C+
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+3.11% 12.54B
A-
Investor Rating
-
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision
-

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. TOI Stock
  4. Ratings The Oncology Institute, Inc.